Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | -5.1x - -5.6x | -5.3x |
| Selected Fwd EBIT Multiple | 0.1x - 0.1x | 0.1x |
| Fair Value | ₩3,907 - ₩4,126 | ₩4,016 |
| Upside | 69.9% - 79.4% | 74.6% |
| Benchmarks | Ticker | Full Ticker |
| QuantaMatrix Inc. | A317690 | KOSDAQ:A317690 |
| iNtRON Biotechnology, Inc. | A048530 | KOSDAQ:A048530 |
| Kangstem Biotech Co., Ltd. | A217730 | KOSDAQ:A217730 |
| Dx & Vx Co., Ltd. | A180400 | KOSDAQ:A180400 |
| Naturalendo Tech Co., Ltd. | A168330 | KOSDAQ:A168330 |
| Helixmith Co., Ltd | A084990 | KOSDAQ:A084990 |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| A317690 | A048530 | A217730 | A180400 | A168330 | A084990 | ||
| KOSDAQ:A317690 | KOSDAQ:A048530 | KOSDAQ:A217730 | KOSDAQ:A180400 | KOSDAQ:A168330 | KOSDAQ:A084990 | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | |
| 3Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | |
| Latest Twelve Months | 28.1% | -59.4% | 2.1% | -39.8% | 7.9% | 49.1% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | -1469.9% | -6.0% | -201.3% | -44.9% | -42.2% | -1277.0% | |
| Prior Fiscal Year | -720.0% | -34.3% | -126.1% | -37.5% | -21.8% | -838.9% | |
| Latest Fiscal Year | -646.7% | -81.6% | -179.3% | -63.6% | -16.9% | -361.0% | |
| Latest Twelve Months | -646.7% | -81.6% | -153.4% | -63.6% | -16.9% | -361.0% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 29.06x | 11.00x | 8.38x | 3.50x | 2.80x | 4.39x | |
| EV / LTM EBITDA | -5.3x | -22.0x | -6.6x | -6.0x | -24.6x | -1.6x | |
| EV / LTM EBIT | -4.5x | -13.5x | -5.5x | -5.5x | -16.6x | -1.2x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -16.6x | -5.5x | -4.5x | ||||
| Historical EV / LTM EBIT | -20.5x | -6.7x | -1.2x | ||||
| Selected EV / LTM EBIT | -5.1x | -5.3x | -5.6x | ||||
| (x) LTM EBIT | (17,955) | (17,955) | (17,955) | ||||
| (=) Implied Enterprise Value | 91,089 | 95,883 | 100,677 | ||||
| (-) Non-shareholder Claims * | 84,048 | 84,048 | 84,048 | ||||
| (=) Equity Value | 175,137 | 179,931 | 184,725 | ||||
| (/) Shares Outstanding | 46.0 | 46.0 | 46.0 | ||||
| Implied Value Range | 3,803.45 | 3,907.56 | 4,011.68 | ||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 3,803.45 | 3,907.56 | 4,011.68 | 2,300.00 | |||
| Upside / (Downside) | 65.4% | 69.9% | 74.4% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | A317690 | A048530 | A217730 | A180400 | A168330 | A084990 | |
| Enterprise Value | 72,572 | 70,622 | 107,089 | 118,760 | 62,381 | 21,860 | |
| (+) Cash & Short Term Investments | 13,112 | 49,776 | 25,821 | 11,214 | 260 | 76,110 | |
| (+) Investments & Other | 1,242 | 11,956 | 7,548 | 8,612 | 872 | 7,720 | |
| (-) Debt | (16,674) | (1,245) | (7,610) | (42,784) | (2,908) | (211) | |
| (-) Other Liabilities | 0 | 0 | 0 | (2,384) | 332 | 429 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 70,251 | 131,109 | 132,848 | 93,417 | 60,937 | 105,908 | |
| (/) Shares Outstanding | 18.1 | 32.0 | 56.1 | 49.2 | 31.6 | 46.0 | |
| Implied Stock Price | 3,885.00 | 4,100.00 | 2,370.00 | 1,898.00 | 1,930.00 | 2,300.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 3,885.00 | 4,100.00 | 2,370.00 | 1,898.00 | 1,930.00 | 2,300.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |